companiesCompany
Adienne Pharma & Biotech
Adienne is a Swiss company specialising in haematology and transplantation medicines; it holds the US and EU authorisations for thiotepa (Tepadina).
Overview
Adienne developed Tepadina (thiotepa) as an orphan medicine for conditioning before haematopoietic stem cell transplantation, authorised in the EU in 2010 and the US in 2017, and markets other transplant-related products in Europe.
Headquarters
Lugano, CH
Scorecard
All companies#63of 680 companies, score 40
- approved products +6
- modalities +2
- regions +2
- registry trials +30
1 approved, 0 in phase 3, 0 earlier, 0 targets, 269 registry studies. Formula on the scorecards page.
Type
pharma
Website